TY - JOUR
T1 - Management, and outcomes of pediatric cerebral cavernous malformations across age groups
T2 - A systematic review and meta-analysis of the literature
AU - Haider, Muhammad Ammar
AU - Azam, Faraaz
AU - Smith, Parker D.
AU - Farid, Michael
AU - Lout, Emerson
AU - Anand, Soummitra
AU - Jenkins, Abigail
AU - Venkatesh, Pooja
AU - Ramirez, Cesar
AU - Darko, Kwadwo
AU - Bah, Momodou G.
AU - Naik, Anant
AU - Barrie, Umaru
AU - Braga, Bruno P.
AU - Whittemore, Brett
N1 - Publisher Copyright:
© 2025
PY - 2025/7
Y1 - 2025/7
N2 - Objective: Pediatric Cerebral Cavernous Malformations (CCM) are focal neuro-vascular lesions with highly variable symptomatic presentations and natural history. In this study, we explored clinical features, management decisions, and outcomes in specific pediatric CCM populations. Methods: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, an exhaustive review of the literature was conducted using search strings on PubMed, SCOPUS, Google Scholar, Ovid Embase, and Cochrane databases to assess differences in patient demographics, treatment strategies and clinical outcomes specifically between National Institute of Health (NIH) and American Academic of Pediatrics (AAP)-defined age groups: infants (0–1 year), children (1–12 years), adolescents (12–17 years). Results: Data from 630 individual pediatric cases from 94 publications was analyzed, yielding 45 infants (median: 0.3 years), 280 children (median: 7.0 years), and 305 adolescents (median: 15 years). Comparatively, infants were more likely to present with signs of elevated ICP and isolated lesions than both the children and adolescents’ group (p < 0.05). Infants presenting with multiple lesions had higher rates of conservative management than surgery (46.2 % vs. 24.30 %, p < 0.01). Children with isolated sensory deficits or asymptomatic at presentation were more likely to undergo conservative management (14.3 % vs. 3.70 %, p < 0.05; 20.0 % vs. 0 %, p < 0.001), while those who underwent surgery had higher rates of improvement (81.6 % vs. 51.4 %, p < 0.001) and were more often symptom-free at follow-up (48.2 % vs. 25.7 %, p < 0.05). In adolescents, seizures (47.1 % vs. 14.8 %, p < 0.01), supratentorial lesions (64.6.0 % vs. 45.2 %, p < 0.01), and isolated lesions (75.7 % vs. 53.8 %, p < 0.05) favored surgical management. With increasing age, headaches were more likely (OR:1.05, 95 % CI:1.01–1.10, p < 0.05), whereas motor deficits (OR:0.96, 95 % CI:0.93–0.99, p < 0.05) and signs of elevated intracranial pressure (OR:0.91, 95 % CI:0.87–0.95, p < 0.001) were less likely initial presentations. Furthermore, older patients were more likely to harbor multiple malformations (OR:1.04, 95 % CI:1.01–1.08, p < 0.05). Regardless of management strategy, there was no difference in long-term outcomes between age groups (p > 0.05). Conclusion: Although presenting symptoms, specific lesion characteristics and symptoms varied with the age of presentation in pediatric CCM patients, there was no significant difference noted in outcomes or long-term follow-up between age groups.
AB - Objective: Pediatric Cerebral Cavernous Malformations (CCM) are focal neuro-vascular lesions with highly variable symptomatic presentations and natural history. In this study, we explored clinical features, management decisions, and outcomes in specific pediatric CCM populations. Methods: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, an exhaustive review of the literature was conducted using search strings on PubMed, SCOPUS, Google Scholar, Ovid Embase, and Cochrane databases to assess differences in patient demographics, treatment strategies and clinical outcomes specifically between National Institute of Health (NIH) and American Academic of Pediatrics (AAP)-defined age groups: infants (0–1 year), children (1–12 years), adolescents (12–17 years). Results: Data from 630 individual pediatric cases from 94 publications was analyzed, yielding 45 infants (median: 0.3 years), 280 children (median: 7.0 years), and 305 adolescents (median: 15 years). Comparatively, infants were more likely to present with signs of elevated ICP and isolated lesions than both the children and adolescents’ group (p < 0.05). Infants presenting with multiple lesions had higher rates of conservative management than surgery (46.2 % vs. 24.30 %, p < 0.01). Children with isolated sensory deficits or asymptomatic at presentation were more likely to undergo conservative management (14.3 % vs. 3.70 %, p < 0.05; 20.0 % vs. 0 %, p < 0.001), while those who underwent surgery had higher rates of improvement (81.6 % vs. 51.4 %, p < 0.001) and were more often symptom-free at follow-up (48.2 % vs. 25.7 %, p < 0.05). In adolescents, seizures (47.1 % vs. 14.8 %, p < 0.01), supratentorial lesions (64.6.0 % vs. 45.2 %, p < 0.01), and isolated lesions (75.7 % vs. 53.8 %, p < 0.05) favored surgical management. With increasing age, headaches were more likely (OR:1.05, 95 % CI:1.01–1.10, p < 0.05), whereas motor deficits (OR:0.96, 95 % CI:0.93–0.99, p < 0.05) and signs of elevated intracranial pressure (OR:0.91, 95 % CI:0.87–0.95, p < 0.001) were less likely initial presentations. Furthermore, older patients were more likely to harbor multiple malformations (OR:1.04, 95 % CI:1.01–1.08, p < 0.05). Regardless of management strategy, there was no difference in long-term outcomes between age groups (p > 0.05). Conclusion: Although presenting symptoms, specific lesion characteristics and symptoms varied with the age of presentation in pediatric CCM patients, there was no significant difference noted in outcomes or long-term follow-up between age groups.
KW - Age
KW - Cavernous malformations
KW - CCM
KW - CCMs
KW - Management
KW - Pediatrics
UR - http://www.scopus.com/inward/record.url?scp=105004209233&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105004209233&partnerID=8YFLogxK
U2 - 10.1016/j.jocn.2025.111289
DO - 10.1016/j.jocn.2025.111289
M3 - Article
C2 - 40327921
AN - SCOPUS:105004209233
SN - 0967-5868
VL - 137
JO - Journal of Clinical Neuroscience
JF - Journal of Clinical Neuroscience
M1 - 111289
ER -